Back to News
Market Impact: 0.15
Rogaine Rides GLP-1 Wave With 30% Sales Surge This Year
Source: Bloomberg
Consumer Demand & RetailHealthcare & Biotech
Rogaine is seeing an unexpected boom as more people take GLP-1 weight-loss drugs. The article provides no sales figures or quantified market impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- Costco is taking aim at its May record high — how it got here and where's it going
- Tapestry CEO on Earnings Beat, Consumer Outlook
- e.l.f. CEO: All of Our Brands Are Growing
- We're raising our price target on Cardinal Health after another stellar quarter of profits
- Here's where we stand on Kimberly-Clark shares after a better-than-feared quarter
- Mattel cuts annual forecasts as new CEO takes charge